Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Cancer
|
June 23, 2009
Genomic approaches to outcome prediction in prostate cancer
Phillip G Febbo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Epigenetic events highlight the challenge of validating prognostic biomarkers during the clinical and biologic evolution of prostate cancer
Phillip G Febbo
Molecular Diagnosis & Therapy
|
December 15, 2007
Genomic signatures associated with the development, progression, and outcome of prostate cancer
Prateek Mendiratta, Phillip G Febbo
Personalized Medicine
|
May 18, 2018
The current and future role of sequence-based analysis in prostate cancer treatment
Won Kim, Phillip G Febbo
Methods in Molecular Biology (Clifton, N.J.)
|
November 3, 2009
Cancer gene profiling in prostate cancer
Adam Foye, Phillip G Febbo
The Journal of Urology
|
November 12, 2003
Use of expression analysis to predict outcome after radical prostatectomy
Phillip G Febbo, William R Sellers
The Oncologist
|
August 18, 2009
Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature
Andrew J Armstrong, Phillip G Febbo
Hematology/Oncology Clinics of North America
|
July 25, 2006
New insights into prostate cancer biology
Bala S Balakumaran, Phillip G Febbo
Personalized Medicine
|
May 24, 2018
Personalized diagnostic and therapeutic strategies in oncology
Phillip G Febbo, Geoffrey S Ginsburg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2006
Noise and bias in microarray analysis of tumor specimens
Phillip G Febbo, Philip W Kantoff
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Cancer
|
June 23, 2009
Genomic approaches to outcome prediction in prostate cancer
Phillip G Febbo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Epigenetic events highlight the challenge of validating prognostic biomarkers during the clinical and biologic evolution of prostate cancer
Phillip G Febbo
Molecular Diagnosis & Therapy
|
December 15, 2007
Genomic signatures associated with the development, progression, and outcome of prostate cancer
Prateek Mendiratta, Phillip G Febbo
Personalized Medicine
|
May 18, 2018
The current and future role of sequence-based analysis in prostate cancer treatment
Won Kim, Phillip G Febbo
Methods in Molecular Biology (Clifton, N.J.)
|
November 3, 2009
Cancer gene profiling in prostate cancer
Adam Foye, Phillip G Febbo
The Journal of Urology
|
November 12, 2003
Use of expression analysis to predict outcome after radical prostatectomy
Phillip G Febbo, William R Sellers
The Oncologist
|
August 18, 2009
Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature
Andrew J Armstrong, Phillip G Febbo
Hematology/Oncology Clinics of North America
|
July 25, 2006
New insights into prostate cancer biology
Bala S Balakumaran, Phillip G Febbo
Personalized Medicine
|
May 24, 2018
Personalized diagnostic and therapeutic strategies in oncology
Phillip G Febbo, Geoffrey S Ginsburg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2006
Noise and bias in microarray analysis of tumor specimens
Phillip G Febbo, Philip W Kantoff
Page
of 8